PharmaResources (Shanghai) Co. Ltd. A (301230.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE1000065Q9
PharmaResources (Shanghai) Co. Ltd. A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 544.47 m CNY | 688.35 m CNY |
| Gross profit | 129.93 m CNY | 188.72 m CNY |
| Operating income | -3.15 m CNY | 43.62 m CNY |
| EBIT | 12.82 m CNY | 36.61 m CNY |
| Net income | 17.08 m CNY | 34.29 m CNY |
| Diluted EPS – continuing operations | 0.12 CNY | 0.19 CNY |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PharmaResources (Shanghai) Co. Ltd. A
PharmaResources (Shanghai) Co., Ltd., together with its subsidiaries, operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally. The company offers contract research organization (CRO), contract manufacturing organization (CMO), contract development and manufacturing organization (CDMO), and commercial manufacturing services for small molecule drugs. It is also involved in the research, development, and customized/commercial production of active pharmaceutical ingredients and key intermediates, including ticagrelor, oxiracetam, l-carnitine, velpatasvir, peramivir trihydrate, huperzine A, and vitamin K2, as well as design, screening, and optimization of hit compounds and lead compounds; conducting of structural improvements; and provision of preliminary safety screening to obtain candidate compounds with outstanding drug properties and intellectual property rights. In addition, the company provides medicinal chemistry, process research and development, pharmaceutical research, molecular building blocks, and pharmacokinetics services. Further, it engages in pharmaceutical technology research and development activities. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China.
More stocks
- GRAHAM CORP (GHM)
- MidCap Financial Investment Corp (MFIC)
- SK Discovery Co Ltd (006120.KS)
- Trican Well Service Ltd. (TCW.TO)
- Power HF Co Ltd (605100.SS)
- Dynamic Holding Co. Ltd. (3715.TW)
- D-MARKET Electronic Services & Trading ADR (HEPS)
- Shenzhen JingQuanHua Electronics Co Ltd (002885.SZ)
- Dr Martens PLC (DOCS.L)
- Beijing Watertek Information Technology Co Ltd (300324.SZ)
- ALERUS FINANCIAL CORP (ALRS)
- RoboSense Technology Co Ltd (2498.HK)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.